GSK-3β inhibitor 1 |
Catalog No.GC36193 |
GSK-3β El inhibidor 1 (compuesto 3a) es un inhibidor de la glucógeno sintasa quinasa 3β (GSK-3β) y demuestra una alta eficacia antidiabética, con una IC50 de 4,9 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 187325-53-7
Sample solution is provided at 25 µL, 10mM.
GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC50 of 4.9 nM[1]. GSK-3β|4.9 nM (IC50)
[1]. Lozinskaya NA, et al. Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors. Bioorg Med Chem. 2019 May 1;27(9):1804-1817.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *